Doctors and patients increasingly ask AI about diseases, treatments and medicines. The answers can be incomplete, outdated or one-sided, and most pharma teams cannot see them. ceel.ai shows Medical Affairs and Commercial teams what AI says about their therapy area, which sources appear in those answers, and what to change before an inaccurate narrative scales. Being mentioned is not the same as being represented correctly. So we look beyond visibility, at scientific accuracy, context and evidence, and turn it into concrete work for your teams: • Congress: see how new data is picked up by AI before, during and after major congresses. • Compliance Shield: spot answers that drift into off-label, outdated or unbalanced territory early. • Publication Planner: find where AI answers lack your evidence and feed that into publication planning. Built for pharma, with scientific accuracy and regulatory boundaries first. Narrative-to-Action for Pharma.
| Website | https://www.ceel.ai/ |
| Employees | 3 (3 on RocketReach) |
| Founded | 2025 |
| Industry | Hospitals and Health Care |
| Keywords | Llm Platform, Brand Analytics, Llm Applications, Actionable Insights, Digital Analytics, Marketing Analytics, Ai Analytics, Ai Platform, Data Analytics, Advanced Analytics, Data Driven Insights, Predictive Analytics, Business Intelligence, Competitive Intelligence, Digital Transformation, Market Research, Customer Insights, Brand Insights |
Looking for a particular ceel.ai employee's phone or email?
Daniel Weimer is the Co-Founder of ceel.ai.
3 people are employed at ceel.ai.